Does AZD-1222 Cause Dyspnoea? 472 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 472 reports of Dyspnoea have been filed in association with AZD-1222. This represents 20.1% of all adverse event reports for AZD-1222.
472
Reports of Dyspnoea with AZD-1222
20.1%
of all AZD-1222 reports
8
Deaths
148
Hospitalizations
How Dangerous Is Dyspnoea From AZD-1222?
Of the 472 reports, 8 (1.7%) resulted in death, 148 (31.4%) required hospitalization, and 105 (22.2%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 472 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Abdominal discomfort (467)
Malaise (467)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which AZD-1222 Alternatives Have Lower Dyspnoea Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT